Spots Global Cancer Trial Database for progesterone

Every month we try and update this database with for progesterone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone	NCT01428089	Polycystic Ovar... Hyperandrogenis... Normal Puberty	Progesterone Placebo	7 Years - 14 Years	University of Virginia
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea	NCT02019589	Secondary Ameno...	Progesterone Placebo	18 Years - 40 Years	TherapeuticsMD
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914	NCT00290251	Leiomyoma	ulipristal acet... ulipristal acet... placebo	25 Years - 50 Years	National Institutes of Health Clinical Center (CC)
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC	NCT03463252	Endometrial Can... Atypical Endome...	Progesterone Mirena® GnRH agonist	- 40 Years	West China Second University Hospital
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer	NCT04046185	Endometrial Can...	PD-1 inhibitor ... progesterone	18 Years - 45 Years	Shanghai First Maternity and Infant Hospital
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst	NCT03456570	Functional Ovar... Progesterone	Dydrogesterone ... Placebo Oral Ta...	18 Years - 44 Years	Assiut University
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)	NCT01718444	Polycystic Ovar... Infertility	Progestin Clomiphene Citr...	18 Years - 40 Years	University of Illinois at Chicago
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)	NCT01718444	Polycystic Ovar... Infertility	Progestin Clomiphene Citr...	18 Years - 40 Years	University of Illinois at Chicago
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone	NCT01428193	Polycystic Ovar... Hyperandrogenis...	Flutamide Progesterone estrace	13 Years - 17 Years	University of Virginia
Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors	NCT04414020	Diffuse Traumat...	Progesteron	20 Years - 65 Years	Minia University
Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition	NCT01425541	Hyperandrogenem... Polycystic Ovar...	estrace Progesterone	8 Years - 18 Years	University of Virginia
The Efficacy of Progestins in Treatment of Functional Ovarian Cyst	NCT03456570	Functional Ovar... Progesterone	Dydrogesterone ... Placebo Oral Ta...	18 Years - 44 Years	Assiut University
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer	NCT05647109	Endometrial Car... Atypical Endome...	No intervention	17 Years - 45 Years	Peking University People's Hospital
Progesterone Action on Endometrium of PCOS	NCT05062135	Polycystic Ovar... Progesterone Re...	Progesterone 40...	18 Years - 35 Years	University of Sao Paulo General Hospital
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition	NCT01428245	Hyperandrogenem... Polycystic Ovar...	Progesterone Estrace (estrog...	8 Years - 14 Years	University of Virginia
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer	NCT04046185	Endometrial Can...	PD-1 inhibitor ... progesterone	18 Years - 45 Years	Shanghai First Maternity and Infant Hospital
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea	NCT02019589	Secondary Ameno...	Progesterone Placebo	18 Years - 40 Years	TherapeuticsMD
Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone	NCT01428089	Polycystic Ovar... Hyperandrogenis... Normal Puberty	Progesterone Placebo	7 Years - 14 Years	University of Virginia
Progesterone Action on Endometrium of PCOS	NCT05062135	Polycystic Ovar... Progesterone Re...	Progesterone 40...	18 Years - 35 Years	University of Sao Paulo General Hospital
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist	NCT00044876	Leiomyoma	CDB-2914	33 Years - 50 Years	National Institutes of Health Clinical Center (CC)
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient	NCT05847660	Polycystic Ovar... Infertility IVF	Progesterone an... conventional an...	20 Years - 40 Years	Fayoum University
Smoking Cessation and Menstrual Cycle Phase	NCT05515354	Nicotine Depend... Tobacco Smoking Smoking Cessati... Nicotine Use Di... Substance Use D...	Timing of nicot... Nicotine Replac...	18 Years - 40 Years	Centre for Addiction and Mental Health
Sex Steroids, Sleep, and Metabolic Dysfunction in Women	NCT00805207	Polycystic Ovar... Obstructive Sle... Obesity	Progesterone testosterone glucocorticoid continuous posi... Estrogen Control	18 Years - 75 Years	Washington University School of Medicine

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: